Troy– Author –
-
Quantum Computing Sector Reports Multi-faceted Progress: Monarch Quantum Secures $55M, Google Shifts to Dual-Modality, India Establishes First Commercial 8-Qubit System, and Fujitsu/Osaka University Advance Molecular Simulation
Quantum Computing Report USA Overview The quantum computing industry witnessed significant advancements across various players in July 2026. Monarch Quantum secured a $55 million growth round led by Serendipity Capital to scale productio... -
IBM and University of Chicago Achieve Trusted Quantum Advantage with 70 Logical Qubits, Outperforming Classical Computation
IBM USA Overview IBM and University of Chicago researchers have demonstrated quantum advantage in trusted computation, executing complex tasks using 70 logical qubits in approximately 15 minutes, a feat practically impossible for classic... -
Scalable Automation in Adherent-Cell Cultures Boosts Yield and Quality: Corning’s HYPERStack and CellCube Systems Key to Efficiency
BioProcess International USA Overview Automation in scaling out adherent cell cultures significantly enhances consistency, proving especially effective where labor and bioprocessing expertise are limited. Automated culture platforms impr... -
Cell & Gene Therapy Manufacturing Faces Deepening Bottlenecks: AmplifyBio, Exothera Close; Thermo Fisher Cuts Viral Vector Jobs, but FDA Eases Regulations to Support Growth
Endpoints News Global Overview Despite cell and gene therapies becoming a commercial reality, manufacturing remains the primary bottleneck. The CDMO sector is struggling with overcapacity and underfunding, leading to closures like Amplif... -
Catalent Bolsters End-to-End CDMO Services for Autologous & Allogeneic Cell Therapies, Including iPSC Center of Excellence
Catalent USA Overview Catalent is enhancing its end-to-end CDMO manufacturing support and process development services for both autologous and allogeneic cell therapies, covering CAR-T, TCR, TIL, NK cells, and iPSC- and MSC-derived treat... -
Vivici Expands High-Purity Lactoferrin Production via Precision Fermentation, Delivering Animal-Free Nutritional Quality and Functionality
Vivici Netherlands Overview Vivici is advancing scalable production of lactoferrin, a rare bioactive protein, through precision fermentation technology. This approach enables access to high-purity lactoferrin without animal reliance, enh... -
All G Unveils Bovine-Free Lactoferrin in U.S. via Precision Fermentation, Establishing Multi-Ton Annual Production Capacity
foodnavigator-usa.com USA Overview All G has announced the launch of bovine-free lactoferrin in the U.S. market, produced using precision fermentation technology, with human-identical protein launch imminent. The company has partnered wi... -
ADM and The EVERY Company Partner to Scale Commercial Production of Precision-Fermented Egg Protein OvoPro, Transforming the Future of Food
flavorist.com USA Overview ADM and The EVERY Company announced a strategic partnership to accelerate commercial-scale production of OvoPro, EVERY's flagship precision-fermented egg protein. This collaboration combines EVERY's proprietary... -
Sartorius Unveils AI-Enabled Ambr 250 HT and Pionic Platform, Sustains Strong H1 2026 Business Growth and Profitability
boerse.de Germany Overview Sartorius Stedim Biotech has expanded its solution portfolio with the launch of the AI-enabled Ambr 250 HT Cell Therapies Vessel and the Pionic platform for intensified continuous bioprocessing. These innovatio... -
Fujifilm Prepares for Patent Cliff with Strategic CDMO Investments; Samsung Biologics Acquires PolyPeptide for $1.8B, Entering Peptide Market
Endpoints News Global Overview The pharmaceutical industry faces a 'patent cliff' with ~$300 billion in branded drug revenues at risk from 2025-2030, driving active deals for portfolio expansion and cost efficiency. Contract Development ...
